Pengenalan

Halaman ini menyediakan analisis menyeluruh tentang sejarah dagangan orang dalam yang diketahui Kenneth Allen Myszkowski. Orang dalam ialah pegawai, pengarah atau pelabur penting dalam syarikat. Adalah haram bagi orang dalam untuk membuat perdagangan dalam syarikat mereka berdasarkan maklumat khusus bukan awam. Ini tidak bermakna haram bagi mereka untuk membuat sebarang perdagangan dalam syarikat mereka sendiri. Tetapi mereka mesti melaporkan semua perdagangan kepada SEC melalui Borang 4. Walaupun terdapat sekatan ini, penyelidikan akademik menunjukkan bahawa orang dalam - secara amnya - cenderung untuk mengatasi prestasi pasaran dalam syarikat mereka sendiri.

Purata Keuntungan Perdagangan

Purata keuntungan perdagangan ialah purata pulangan semua pembelian pasaran terbuka yang dibuat oleh orang dalam dalam tempoh tiga tahun terakhir. Untuk mengira ini, kami memeriksa setiap pembelian pasaran terbuka yang tidak dirancang oleh orang dalam, tidak termasuk semua dagangan yang ditandakan sebagai sebahagian daripada pelan dagangan 10b5-1. Kami kemudian mengira prestasi purata dagangan tersebut sepanjang 3, 6 dan 12 bulan, dengan purata setiap tempoh tersebut untuk menjana metrik prestasi akhir bagi setiap dagangan. Akhir sekali, kami puratakan semua metrik prestasi untuk mengira metrik prestasi untuk orang dalam. Senarai ini hanya termasuk orang dalam yang telah membuat sekurang-kurangnya tiga dagangan dalam dua tahun lepas.

Jika keuntungan berdagang orang dalam ini ialah "N/A", maka orang dalam sama ada tidak membuat sebarang pembelian pasaran terbuka dalam tempoh tiga tahun terakhir, atau dagangan yang mereka buat adalah terlalu baru untuk mengira metrik prestasi yang boleh dipercayai.

Kekerapan Kemas Kini: Harian

Lihat senarai pedagang dalaman yang paling menguntungkan.

Lihat Orang Dalam Dengan Kedudukan Tertinggi
Syarikat dengan Kedudukan Orang Dalam yang Dilaporkan

Pemfailan SEC menunjukkan Kenneth Allen Myszkowski telah melaporkan pegangan atau perdagangan dalam syarikat berikut:

Sekuriti Tajuk Pegangan Terkini Dilaporkan
US:ARWR / Arrowhead Pharmaceuticals, Inc. Chief Financial Officer 455,433
Bagaimana Mentafsir Carta

Carta berikut menunjukkan prestasi saham sekuriti selepas setiap dagangan pasaran terbuka dan tidak dirancang yang dibuat oleh Kenneth Allen Myszkowski. Perdagangan tidak dirancang ialah dagangan yang tidak dibuat sebagai sebahagian daripada pelan dagangan 10b5-1. Prestasi saham dicatatkan sebagai perubahan peratus kumulatif dalam harga saham. Sebagai contoh, jika perdagangan orang dalam dibuat pada 1 Januari 2019, carta akan menunjukkan perubahan peratusan harian sekuriti kepada hari ini. Jika harga saham naik dari $10 kepada $15 pada masa ini, perubahan peratus terkumpul dalam harga saham ialah 50%. Perubahan dalam harga daripada $10 kepada $20 ialah 100% dan perubahan dalam harga $10 hingga $5 ialah -50%.

Secara dasarnya, kami cuba untuk menentukan sejauh mana dagangan orang dalam berkait rapat dengan pulangan berlebihan (positif atau negatif) dalam harga saham untuk melihat sama ada orang dalam menetapkan masa dagangan mereka untuk mendapat keuntungan daripada maklumat orang dalam. Pertimbangkan situasi di mana orang dalam melakukan perkara ini. Dalam keadaan ini, kami menjangkakan sama ada (a) pulangan positif selepas pembelian, atau (b) pulangan negatif selepas jualan. Dalam kes (a), carta PEMBELIAN akan menunjukkan satu siri keluk condong ke atas, menunjukkan pulangan positif selepas setiap transaksi pembelian. Dalam kes (b), carta JUALAN akan menunjukkan satu siri keluk condong ke bawah, menunjukkan pulangan negatif selepas setiap transaksi jualan.

Walau bagaimanapun, ini sahaja tidak cukup untuk membuat kesimpulan. Jika, sebagai contoh, harga saham syarikat berada dalam pendakian bukan disebabkan kitaran selama bertahun-tahun, maka kami menjangkakan semua plot selepas pembelian akan condong ke atas. Begitu juga, kemerosotan bukan disebabkan kitaran selama bertahun-tahun akan mengakibatkan plot pasca perdagangan condong ke bawah. Kedua-dua carta ini tidak akan mencadangkan aktiviti perdagangan orang dalam.

Penunjuk terkuat ialah keadaan di mana harga saham adalah sangat kitaran, dan terdapat kedua-dua isyarat positif dalam carta PEMBELIAN dan plot negatif pada carta JUALAN. Situasi ini akan sangat menunjukkan orang dalam yang menentukan masa perdagangan untuk kelebihan kewangan mereka.

Sejarah Dagangan Orang Dalam

Jadual ini menunjukkan senarai lengkap dagangan orang dalam yang dibuat oleh Kenneth Allen Myszkowski seperti yang didedahkan kepada Suruhanjaya Bursa Sekuriti (SEC).

Tarikh Fail Tarikh Tran Borang Simbol Saham Sekuriti Kod 10b5-1 Saham Baki Saham Peratus
Ubah		 Saham
harga		 Tran
Nilai		 Baki
Nilai
2025-01-07 2025-01-07 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		S - Sale -10,000 455,433 -2.15 19.69 -196,900 8,967,476
2025-01-07 2025-01-07 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		S - Sale X -8,000 465,433 -1.69 19.70 -157,600 9,169,030
2025-01-07 2025-01-06 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		S - Sale X -9,402 473,433 -1.95 20.10 -188,980 9,516,003
2025-01-07 2025-01-06 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		S - Sale X -17,765 482,835 -3.55 19.68 -349,615 9,502,193
2025-01-07 2025-01-04 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		A - Award 100,000 500,600 24.96
2024-03-08 2024-03-06 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		S - Sale -40,000 400,600 -9.08 35.19 -1,407,600 14,097,114
2024-01-08 2024-01-05 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		S - Sale X -8,904 440,600 -1.98 35.65 -317,428 15,707,390
2024-01-08 2024-01-05 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		S - Sale X -5,800 449,504 -1.27 34.97 -202,826 15,719,155
2024-01-08 2024-01-05 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		S - Sale X -1,400 455,304 -0.31 34.04 -47,656 15,498,548
2024-01-08 2024-01-04 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		A - Award 75,000 456,704 19.65
2023-06-29 2023-06-27 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		S - Sale -15,000 381,704 -3.78 36.20 -543,000 13,817,685
2023-01-05 2023-01-04 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		A - Award 60,000 396,704 17.82
2022-12-30 2022-12-29 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		S - Sale X -30,625 336,704 -8.34 40.00 -1,225,000 13,468,160
2022-09-30 2022-06-15 5 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		G - Gift -96,676 367,329 -20.84
2022-01-06 2022-01-05 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		S - Sale X -3,786 464,005 -0.81 63.95 -242,115 29,673,120
2022-01-06 2022-01-05 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		S - Sale X -3,778 467,791 -0.80 63.17 -238,656 29,550,357
2022-01-06 2022-01-05 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		S - Sale X -16,528 471,569 -3.39 62.00 -1,024,736 29,237,278
2022-01-06 2022-01-05 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		S - Sale X -15,908 488,097 -3.16 60.50 -962,434 29,529,868
2022-01-04 2022-01-01 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		A - Award 60,000 504,005 13.51
2021-01-12 2021-01-12 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		S - Sale -1,441 444,005 -0.32 81.00 -116,721 35,964,405
2021-01-12 2021-01-11 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		S - Sale -11,597 445,446 -2.54 81.02 -939,589 36,090,035
2021-01-07 2021-01-06 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		S - Sale X -25,166 457,043 -5.22 72.63 -1,827,807 33,195,033
2021-01-07 2021-01-06 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		S - Sale X -4,359 482,209 -0.90 71.77 -312,845 34,608,140
2021-01-07 2021-01-06 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		S - Sale X -1,100 486,568 -0.23 70.75 -77,825 34,424,686
2021-01-05 2021-01-01 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		A - Award 60,000 487,668 14.03
2020-11-12 2020-11-09 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Stock Option (right to buy) 		M - Exercise -43,505 0 -100.00
2020-11-12 2020-11-09 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		S - Sale -17,665 427,668 -3.97 69.86 -1,234,077 29,876,886
2020-11-12 2020-11-09 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		S - Sale -25,840 445,333 -5.48 69.04 -1,783,994 30,745,790
2020-11-12 2020-11-09 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 43,505 471,173 10.17 14.54 632,563 6,850,855
2020-10-22 2020-10-20 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Stock Option (right to buy) 		M - Exercise -29,166 43,505 -40.13
2020-10-22 2020-10-20 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		S - Sale -29,166 427,668 -6.38 54.04 -1,576,131 23,111,179
2020-10-22 2020-10-20 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 29,166 456,834 6.82 6.15 179,371 2,809,529
2020-02-27 2020-02-25 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Stock Option (right to buy) 		M - Exercise -10,834 72,671 -12.97
2020-02-27 2020-02-25 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Stock Option (right to buy) 		M - Exercise -12,116 83,505 -12.67
2020-02-27 2020-02-25 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Stock Option (right to buy) 		M - Exercise -6,495 95,621 -6.36
2020-02-27 2020-02-25 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Stock Option (right to buy) 		M - Exercise -2,000 102,116 -1.92
2020-02-27 2020-02-25 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Stock Option (right to buy) 		M - Exercise -12,000 104,116 -10.33
2020-02-27 2020-02-25 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 10,834 427,668 2.60 6.15 66,629 2,630,158
2020-02-27 2020-02-25 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 12,116 416,834 2.99 7.75 93,899 3,230,464
2020-02-27 2020-02-25 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 6,495 404,718 1.63 14.54 94,437 5,884,600
2020-02-27 2020-02-25 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 2,000 398,223 0.50 5.19 10,380 2,066,777
2020-02-27 2020-02-25 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 12,000 396,223 3.12 9.90 118,800 3,922,608
2020-01-23 2020-01-21 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Stock Option (right to buy) 		M - Exercise -33,351 116,116 -22.31
2020-01-23 2020-01-21 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		S - Sale X -3,450 384,223 -0.89 52.13 -179,848 20,029,545
2020-01-23 2020-01-21 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		S - Sale X -10,680 387,673 -2.68 51.11 -545,855 19,813,967
2020-01-23 2020-01-21 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		S - Sale X -2,800 398,353 -0.70 49.98 -139,944 19,909,683
2020-01-23 2020-01-21 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		S - Sale X -10,554 401,153 -2.56 49.07 -517,885 19,684,578
2020-01-23 2020-01-21 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		S - Sale X -6,432 411,707 -1.54 47.93 -308,286 19,733,117
2020-01-23 2020-01-21 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		S - Sale X -6,397 418,139 -1.51 47.07 -301,107 19,681,803
2020-01-23 2020-01-21 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 33,351 424,536 8.53 5.19 173,092 2,203,342
2020-01-08 2020-01-06 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		S - Sale X -500 391,185 -0.13 60.95 -30,475 23,842,726
2020-01-08 2020-01-06 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		S - Sale X -11,907 391,685 -2.95 60.40 -719,183 23,657,774
2020-01-08 2020-01-06 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		S - Sale X -7,593 403,592 -1.85 59.60 -452,543 24,054,083
2020-01-03 2020-01-01 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		A - Award 85,000 411,185 26.06
2019-11-07 2019-11-05 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Stock Option (right to buy) 		M - Exercise -12,649 149,467 -7.80
2019-11-07 2019-11-05 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 12,649 326,185 4.03 5.19 65,648 1,692,900
2019-11-01 2019-11-01 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Stock Option (right to buy) 		M - Exercise -37,884 162,116 -18.94
2019-11-01 2019-11-01 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		S - Sale X -16,620 313,536 -5.03 41.21 -684,910 12,920,819
2019-11-01 2019-11-01 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		S - Sale X -21,264 330,156 -6.05 40.56 -862,468 13,391,127
2019-11-01 2019-11-01 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 37,884 351,420 12.08 7.75 293,601 2,723,505
2019-06-03 2019-05-31 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Stock Option (right to buy) 		M - Exercise -20,000 200,000 -9.09
2019-06-03 2019-05-31 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Stock Option (right to buy) 		M - Exercise -15,000 220,000 -6.38
2019-06-03 2019-05-31 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 20,000 313,536 6.81 5.19 103,800 1,627,252
2019-06-03 2019-05-31 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 15,000 293,536 5.39 4.60 69,000 1,350,266
2019-05-22 2019-05-21 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		S - Sale X -27,071 278,536 -8.86 22.00 -595,562 6,127,792
2019-02-20 2019-02-19 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Stock Option (right to buy) 		M - Exercise -8,000 235,000 -3.29
2019-02-20 2019-02-19 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		S - Sale X -8,000 305,607 -2.55 18.00 -144,000 5,500,926
2019-02-20 2019-02-19 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 8,000 313,607 2.62 5.20 41,600 1,630,756
2019-01-18 2019-01-17 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		S - Sale X -81,875 305,607 -21.13 14.55 -1,191,281 4,446,582
2019-01-03 2019-01-02 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		S - Sale -8,333 387,482 -2.11 11.98 -99,829 4,642,034
2019-01-03 2019-01-01 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		A - Award 85,000 395,815 27.35
2018-09-10 2018-09-06 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Stock Option (right to buy) 		M - Exercise -20,000 243,000 -7.60
2018-09-10 2018-09-06 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Stock Option (right to buy) 		M - Exercise -25,000 263,000 -8.68
2018-09-10 2018-09-06 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		S - Sale X -20,000 310,815 -6.05 21.01 -420,200 6,530,223
2018-09-10 2018-09-06 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		S - Sale X -25,000 330,815 -7.03 18.00 -450,000 5,954,670
2018-09-10 2018-09-06 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 20,000 355,815 5.96 4.75 95,000 1,690,121
2018-09-10 2018-09-06 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 25,000 335,815 8.04 2.62 65,500 879,835
2018-06-20 2018-06-19 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Stock Option (right to buy) 		M - Exercise -20,000 288,000 -6.49
2018-06-20 2018-06-19 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		S - Sale X -20,000 310,815 -6.05 14.01 -280,200 4,354,518
2018-06-20 2018-06-19 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 20,000 330,815 6.43 2.01 40,200 664,938
2018-06-01 2018-05-31 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Stock Option (right to buy) 		M - Exercise -12,600 308,000 -3.93
2018-06-01 2018-05-31 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		S - Sale X -12,600 310,815 -3.90 11.00 -138,600 3,418,965
2018-06-01 2018-05-31 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 12,600 323,415 4.05 2.01 25,326 650,064
2018-06-01 2018-05-30 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Stock Option (right to buy) 		M - Exercise -1,400 320,600 -0.43
2018-06-01 2018-05-30 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		S - Sale X -1,400 310,815 -0.45 11.00 -15,400 3,418,965
2018-06-01 2018-05-30 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 1,400 312,215 0.45 2.01 2,814 627,552
2018-03-27 2018-03-27 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Stock Option (right to buy) 		M - Exercise -20,000 322,000 -5.85
2018-03-27 2018-03-27 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		S - Sale X -20,000 310,815 -6.05 8.00 -160,000 2,486,520
2018-03-27 2018-03-27 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 20,000 330,815 6.43 2.01 40,200 664,938
2018-03-05 2018-03-05 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		F - Taxes -8,208 310,815 -2.57 6.66 -54,665 2,070,028
2018-01-03 2018-01-01 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		A - Award 75,000 319,023 30.73
2017-10-06 2017-06-08 5 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		G - Gift -16,666 244,023 -6.39
2017-01-04 2017-01-01 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		A - Award 145,000 260,689 125.34
2016-08-26 2016-08-23 4/A ARWR ARROWHEAD PHARMACEUTICALS, INC.
Stock Option (right to buy) 		M - Exercise -6,900 342,000 -1.98
2016-08-26 2016-08-23 4/A ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		S - Sale X -6,900 115,689 -5.63 8.00 -55,200 925,512
2016-08-26 2016-08-23 4/A ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 6,900 122,589 5.96 2.01 13,869 246,404
2016-08-26 2016-08-22 4/A ARWR ARROWHEAD PHARMACEUTICALS, INC.
Stock Option (right to buy) 		M - Exercise -13,100 348,900 -3.62
2016-08-26 2016-08-22 4/A ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		S - Sale X -13,100 115,689 -10.17 8.00 -104,800 925,512
2016-08-26 2016-08-22 4/A ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 13,100 128,789 11.32 2.01 26,331 258,866
2016-08-24 2016-08-23 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Stock Option (right to buy) 		M - Exercise -6,900 342,000 -1.98
2016-08-24 2016-08-23 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		S - Sale -6,900 115,689 -5.63 8.00 -55,200 925,512
2016-08-24 2016-08-23 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 6,900 122,589 5.96 2.01 13,869 246,404
2016-08-24 2016-08-22 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Stock Option (right to buy) 		M - Exercise -13,100 348,900 -3.62
2016-08-24 2016-08-22 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		S - Sale -13,100 115,689 -10.17 8.00 -104,800 925,512
2016-08-24 2016-08-22 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 13,100 128,789 11.32 2.01 26,331 258,866
2016-03-08 2016-03-04 4 ARWR ARROWHEAD RESEARCH CORP
Common Stock 		F - Taxes -6,263 115,689 -5.14 4.33 -27,119 500,933
2016-02-09 2016-02-06 4 ARWR ARROWHEAD RESEARCH CORP
Common Stock 		F - Taxes -13,048 121,952 -9.67 3.46 -45,146 421,954
2016-01-04 2016-01-01 4 ARWR ARROWHEAD RESEARCH CORP
Stock Option 		A - Award 40,000 362,000 12.42
2016-01-04 2016-01-01 4 ARWR ARROWHEAD RESEARCH CORP
Common Stock 		A - Award 50,000 135,000 58.82
2016-01-04 2015-12-30 4 ARWR ARROWHEAD RESEARCH CORP
Common Stock 		S - Sale -23,347 85,000 -21.55 6.13 -143,117 521,050
2016-01-04 2015-12-30 4 ARWR ARROWHEAD RESEARCH CORP
Common Stock 		F - Taxes -13,153 108,347 -10.83 6.13 -80,628 664,167
2015-03-06 2015-03-06 4 ARWR ARROWHEAD RESEARCH CORP
Stock Option 		A - Award 50,000 322,000 18.38
2015-03-06 2015-03-04 4 ARWR ARROWHEAD RESEARCH CORP
Common Stock 		A - Award 50,000 121,500 69.93
2014-08-19 2014-08-15 4 ARWR ARROWHEAD RESEARCH CORP
Stock Option (right to buy) 		M - Exercise -25,000 272,000 -8.42
2014-08-19 2014-08-15 4 ARWR ARROWHEAD RESEARCH CORP
Stock Option (right to buy) 		M - Exercise -15,000 297,000 -4.81
2014-08-19 2014-08-15 4 ARWR ARROWHEAD RESEARCH CORP
Common Stock 		S - Sale -40,000 71,500 -35.87 14.02 -560,860 1,002,537
2014-08-19 2014-08-15 4 ARWR ARROWHEAD RESEARCH CORP
Common Stock 		M - Exercise 25,000 111,500 28.90 7.00 175,000 780,500
2014-08-19 2014-08-15 4 ARWR ARROWHEAD RESEARCH CORP
Common Stock 		M - Exercise 15,000 86,500 20.98 5.19 77,850 448,935
2014-02-12 2014-02-12 4 ARWR ARROWHEAD RESEARCH CORP
Stock Option 		M - Exercise -16,000 312,000 -4.88
2014-02-12 2014-02-12 4 ARWR ARROWHEAD RESEARCH CORP
Common Stock 		S - Sale -16,000 71,500 -18.29 18.77 -300,290 1,341,919
2014-02-12 2014-02-12 4 ARWR ARROWHEAD RESEARCH CORP
Common Stock 		M - Exercise 16,000 87,500 22.38 2.01 32,160 175,875
2014-02-10 2014-02-06 4 ARWR ARROWHEAD RESEARCH CORP
Stock Options 		A - Award 50,000 328,000 17.99
2014-02-10 2014-02-06 4 ARWR ARROWHEAD RESEARCH CORP
Common Stock 		A - Award 70,000 71,500 4,666.67
2013-09-24 2013-09-21 4 ARWR ARROWHEAD RESEARCH CORP
Stock Option 		A - Award 20,000 278,000 7.75
2013-05-08 2013-05-06 4 ARWR ARROWHEAD RESEARCH CORP
Stock Option 		A - Award 90,000 258,000 53.57
2012-10-02 2012-09-28 4 ARWR ARROWHEAD RESEARCH CORP
Stock Option 		A - Award 25,000 168,000 17.48
2012-02-21 2012-02-16 4 ARWR ARROWHEAD RESEARCH CORP
Stock Option 		A - Award 83,000 143,000 138.33
P
Pasaran terbuka atau pembelian persendirian sekuriti bukan derivatif atau derivatif
S
Pasaran terbuka atau jualan persendirian sekuriti bukan derivatif atau derivatif
A
Pemberian, penganugerahan atau pemerolehan lain sekuriti daripada syarikat (seperti opsyen)
C
Penukaran derivatif
D
Penjualan atau pemindahan sekuriti kembali kepada syarikat
F
Pembayaran harga pelaksanaan atau liabiliti cukai menggunakan sebahagian daripada sekuriti yang diterima daripada syarikat
G
Hadiah sekuriti oleh atau kepada orang dalam
K
Swap ekuiti dan urus niaga lindung nilai yang serupa
M
Pelaksanaan atau penukaran sekuriti derivatif yang diterima daripada syarikat (seperti opsyen)
V
Transaksi dilaporkan secara sukarela pada Borang 4
J
Lain-lain (disertai dengan nota kaki yang menerangkan transaksi)